89bio Inc [ETNB] stock prices are down -0.17% to $11.41 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The ETNB shares have gain 18.85% over the last week, with a monthly amount glided 54.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
On January 12, 2024, downgrade downgraded it’s rating to Sector Perform and revised its price target to $15 on the stock. Oppenheimer downgraded its rating to a Perform. UBS initiated its recommendation with a Buy and recommended $36 as its price target on August 28, 2023. Evercore ISI started tracking with a Outperform rating for this stock on June 13, 2023, and assigned it a price target of $49. In a note dated May 12, 2022, Raymond James upgraded an Strong Buy rating on this stock and revised its target price from $33 to $12.
The stock price of 89bio Inc [ETNB] has been fluctuating between $5.99 and $16.63 over the past year. Currently, Wall Street analysts expect the stock to reach $22 within the next 12 months. 89bio Inc [NASDAQ: ETNB] shares were valued at $11.41 at the most recent close of the market. An investor can expect a potential return of 92.81% based on the average ETNB price forecast.
Analyzing the ETNB fundamentals
Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -1298.53%, Pretax Profit Margin comes in at -1216.49%, and Net Profit Margin reading is -1234.87%. To continue investigating profitability, this company’s Return on Assets is posted at -0.63, Equity is -0.6 and Total Capital is -0.72. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.11 points at the first support level, and at 10.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.64, and for the 2nd resistance point, it is at 11.87.
Ratios To Look Out For
It’s worth pointing out that 89bio Inc [NASDAQ:ETNB]’s Current Ratio is 11.65. Further, the Quick Ratio stands at 11.65, while the Cash Ratio is 2.34.
Transactions by insiders
Recent insider trading involved RA CAPITAL MANAGEMENT, L.P., Director, that happened on Jan 30 ’25 when 5.71 million shares were purchased. Director, McWherter Charles completed a deal on Jan 22 ’25 to buy 10000.0 shares. Meanwhile, Director McWherter Charles bought 5000.0 shares on Jan 21 ’25.
